Creo Medical Group Plc

Creo Medical Group Plc CREO

Dividend Summary



There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status
Type
Per share
Declaration date
Ex-div date
Pay date

Enter the number of Creo Medical Group Plc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for Creo Medical Group Plc
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Creo Medical Group Plc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
There are no Creo Medical Group Plc dividends.
Year Amount Change
2006 0.0p
2007 0.0p
0%
2008 0.0p
0%
2009 0.0p
0%
2010 0.0p
0%
2011 0.0p
0%
2012 0.0p
0%
2013 0.0p
0%
2014 0.0p
0%
2015 0.0p
0%
2016 0.0p
0%
2017 0.0p
0%
2018 0.0p
0%
2019 0.0p
0%
2020 0.0p
0%
2021 0.0p
0%
2022 0.0p
0%
2023 0.0p
0%
2024 Sign Up Required

Creo Medical Group Plc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 19 December 2023
52 Week Low
0.0% on 19 December 2023
Next Ex-Div-Date Countdown
Sign Up Required

About Creo Medical Group Plc


Creo Medical Group plc is engaged in the research and development and the manufacture and sale of medical devices and instruments. The Company is focused on the research, development, and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. It has four technology families, which include Speedboat, SpydrBlade, MicroBlate, and SlypSeal. Speedboat is its flagship advanced energy device product with over 1,000 procedures performed using the device. Speedboat device technology is a device technology with bipolar surgical dissection blade in any form of surgery. Additionally, Speedboat integrates microwave technology allowing for precise control of bleeding during surgery. The Company's SpydrBlade device technology optimizes the power of its CROMA Platform, where advanced bipolar radiofrequency (RF) energy is used to cut tissue and precisely controlled microwave energy is used for the coagulation and sealing of tissue during surgery.

Sector
Health Care Equipment & Services
Country
United Kingdom
Share Price
£0.17 (yesterday's closing price)
Shares in Issue
412 million
Market Cap
£71mn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
No articles found